首页 > 最新文献

Ceska a Slovenska Oftalmologie最新文献

英文 中文
Calculation of Intraocular Lens in Patients after Previous Laser Refractive Surgery. 既往激光屈光手术患者人工晶状体的计算。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.31348/2025/22
Eva Maláková, Andrea Janeková

Aim: The incidence of cataract surgery in patients after previous laser refractive surgery is increasing worldwide. However, the resulting uncorrected distance visual acuity (UDVA) after cataract surgery in these patients is less frequently satisfactory. The aim of this article is to present the results of cataract surgery in a group of patients who had undergone previous laser refractive surgery, in whom the IOL power was calculated only according to the currently measured values, and to compare them with the results from other workplaces.

Material and methods: Our group incorporates 69 eyes of 43 patients. The data collection took place over a period of 33 months. The group included patients who attended at least one follow-up examination in the postoperative period. The resulting postoperative vision was considered to be vision determined at least 1 month after cataract surgery. Data were collected retrospectively.

Results: The resulting postoperative average monocular best corrected distance visual acuity (BCDVA) in the patients from our cohort was 0.024 LogMAR in the group of initially myopic patients and 0.030 LogMAR in the group of initially hypermetropic patients. Thus, BCDVA in myopic was better than in hypermetropic patients, without a statistically significant difference. Conversely, the resulting mean manifest spherical equivalent (MSE) was higher for myopic patients (-0.844) than for hypermetropic patients (-0.658), and this difference was evaluated as statistically significant. A refractive result above ±0.5 Dsf was present in 14 eyes, above ±1.0 Dsf in 6 eyes.

Conclusion: In 90% of patients we achieved an average MSE up to ±1.0 Dsf postoperatively. The results from our report regarding postoperative monocular BCDVA, BCNVA, mean SE and MSE are consistent with those from other reports dealing with this issue, although our cohort included a much smaller group of patients.

目的:在世界范围内,激光屈光手术后白内障手术的发生率呈上升趋势。然而,这些患者白内障手术后的未矫正距离视力(UDVA)往往不令人满意。本文的目的是介绍一组接受过激光屈光手术的患者的白内障手术结果,这些患者的人工晶状体度数仅根据当前测量值计算,并将其与其他工作场所的结果进行比较。材料与方法:本组纳入43例69眼。数据收集持续了33个月。该组包括在术后至少参加一次随访检查的患者。术后视力被认为是白内障手术后至少1个月的视力测定。回顾性收集资料。结果:本组患者术后平均单眼最佳矫正距离视力(BCDVA),初诊近视组为0.024 LogMAR,初诊远视组为0.030 LogMAR。因此,近视患者BCDVA优于远视患者,差异无统计学意义。相反,近视患者的平均显球当量(MSE)(-0.844)高于远视患者(-0.658),这一差异具有统计学意义。屈光结果大于±0.5 Dsf者14眼,大于±1.0 Dsf者6眼。结论:90%的患者术后平均MSE达到±1.0 Dsf。我们的报告中关于术后单眼BCDVA、BCNVA、平均SE和MSE的结果与其他关于该问题的报告一致,尽管我们的队列纳入的患者组要小得多。
{"title":"Calculation of Intraocular Lens in Patients after Previous Laser Refractive Surgery.","authors":"Eva Maláková, Andrea Janeková","doi":"10.31348/2025/22","DOIUrl":"10.31348/2025/22","url":null,"abstract":"<p><strong>Aim: </strong>The incidence of cataract surgery in patients after previous laser refractive surgery is increasing worldwide. However, the resulting uncorrected distance visual acuity (UDVA) after cataract surgery in these patients is less frequently satisfactory. The aim of this article is to present the results of cataract surgery in a group of patients who had undergone previous laser refractive surgery, in whom the IOL power was calculated only according to the currently measured values, and to compare them with the results from other workplaces.</p><p><strong>Material and methods: </strong>Our group incorporates 69 eyes of 43 patients. The data collection took place over a period of 33 months. The group included patients who attended at least one follow-up examination in the postoperative period. The resulting postoperative vision was considered to be vision determined at least 1 month after cataract surgery. Data were collected retrospectively.</p><p><strong>Results: </strong>The resulting postoperative average monocular best corrected distance visual acuity (BCDVA) in the patients from our cohort was 0.024 LogMAR in the group of initially myopic patients and 0.030 LogMAR in the group of initially hypermetropic patients. Thus, BCDVA in myopic was better than in hypermetropic patients, without a statistically significant difference. Conversely, the resulting mean manifest spherical equivalent (MSE) was higher for myopic patients (-0.844) than for hypermetropic patients (-0.658), and this difference was evaluated as statistically significant. A refractive result above ±0.5 Dsf was present in 14 eyes, above ±1.0 Dsf in 6 eyes.</p><p><strong>Conclusion: </strong>In 90% of patients we achieved an average MSE up to ±1.0 Dsf postoperatively. The results from our report regarding postoperative monocular BCDVA, BCNVA, mean SE and MSE are consistent with those from other reports dealing with this issue, although our cohort included a much smaller group of patients.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"81 Ahead of Print","pages":"312-317"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144486451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prevalence of Fuchs' Endothelial Corneal Dystrophy in Cataract Patients within the Czech Population. 捷克人群中白内障患者的富克斯角膜内皮营养不良患病率。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.31348/2025/46
Pavel Studený, Jakub Dítě, Martin Horák, Klára Cenková, Zbyněk Straňák, Magdalena Netuková

Aims:  To determine the incidence of Fuchs' endothelial corneal dystrophy (FECD) in patients undergoing cataract surgery in the Czech population.

Material and methods:  Consecutive group of 2804 eyes of 1499 patients undergoing cataract surgery at the Lexum Karlovy Vary clinic in the period from 4/2022 to 9/2024. The corneal endothelium was examined preoperatively using a slit lamp and an endothelial microscope. The corneas were divided into 6 grades (0-5) according to the Krachmer scale, or 4 clinical stages of the disease.

Results:  The incidence of FECD in our group of patients undergoing cataract surgery was 29.6% (total 840 eyes). In 578 cases this concerned stage 1 of the disease, which had no effect on the outcome of the operation. In 81 cases it concerned a stage 3-5 disease, in which potential postoperative complications must be taken into account. In 13 cases (0.46%) we primarily performed a combined procedure of cataract surgery and DMEK (Descemet's membrane endothelial keratoplasty).

Conclusion:  FECD in the population of cataract patients is probably often under-diagnosed. In our cohort of patients we registered some signs of the disease in more than a quarter of the patients.

目的:确定捷克人群中白内障手术患者的富克斯内皮性角膜营养不良(FECD)的发生率。材料与方法:于2022年4月至2024年9月在Lexum Karlovy Vary诊所接受白内障手术的1499例患者,连续组2804只眼。术前应用裂隙灯和内皮显微镜检查角膜内皮。根据Krachmer量表将角膜分为6个等级(0-5级),即疾病的4个临床分期。结果:本组白内障手术患者FECD发生率为29.6%(共840眼)。在578例病例中,这涉及疾病的第1阶段,对手术结果没有影响。81例涉及3-5期疾病,其中必须考虑潜在的术后并发症。在13例(0.46%)中,我们主要采用白内障手术和DMEK (Descemet的膜内皮角膜移植术)联合手术。结论:FECD在白内障患者群体中可能经常被误诊。在我们的患者队列中,我们在超过四分之一的患者中发现了这种疾病的一些迹象。
{"title":"The Prevalence of Fuchs' Endothelial Corneal Dystrophy in Cataract Patients within the Czech Population.","authors":"Pavel Studený, Jakub Dítě, Martin Horák, Klára Cenková, Zbyněk Straňák, Magdalena Netuková","doi":"10.31348/2025/46","DOIUrl":"https://doi.org/10.31348/2025/46","url":null,"abstract":"<p><strong>Aims: </strong> To determine the incidence of Fuchs' endothelial corneal dystrophy (FECD) in patients undergoing cataract surgery in the Czech population.</p><p><strong>Material and methods: </strong> Consecutive group of 2804 eyes of 1499 patients undergoing cataract surgery at the Lexum Karlovy Vary clinic in the period from 4/2022 to 9/2024. The corneal endothelium was examined preoperatively using a slit lamp and an endothelial microscope. The corneas were divided into 6 grades (0-5) according to the Krachmer scale, or 4 clinical stages of the disease.</p><p><strong>Results: </strong> The incidence of FECD in our group of patients undergoing cataract surgery was 29.6% (total 840 eyes). In 578 cases this concerned stage 1 of the disease, which had no effect on the outcome of the operation. In 81 cases it concerned a stage 3-5 disease, in which potential postoperative complications must be taken into account. In 13 cases (0.46%) we primarily performed a combined procedure of cataract surgery and DMEK (Descemet's membrane endothelial keratoplasty).</p><p><strong>Conclusion: </strong> FECD in the population of cataract patients is probably often under-diagnosed. In our cohort of patients we registered some signs of the disease in more than a quarter of the patients.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"81 Ahead of Print","pages":"1-7"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stereotactic Radiosurgery Outcomes in Uveal Melanoma Patients: A 3-year Retrospective Study. 立体定向放射手术治疗葡萄膜黑色素瘤的疗效:一项3年回顾性研究。
Q4 Medicine Pub Date : 2025-01-01 DOI: 10.31348/2025/48
Jozef Sklenka, Pavla Horňáčková, Daniela Vysloužilová, Veronika Matušková, Jan Němčanský, Radoslava Uhmannová, Moussa Goutaib, Oldřich Chrapek

Aim:  To evaluate the three-year survival rate, local tumor control rate and complications of stereotactic radiosurgery in patients with uveal melanoma and compare the outcomes with the available literature.

Material and methods:  In this study, data were evaluated from 122 patients treated for uveal melanoma, of whom 33 met the inclusion criteria for retrospective analysis of stereotactic radiosurgery outcomes using the CyberKnife system. These patients received radiotherapy for uveal melanoma during the period of 2016-2021. The data were collected during regular follow-up visits consisting of best-corrected visual acuity assessment, slit-lamp examination, indirect ophthalmoscopy, intraocular pressure measurement and ultrasound measurement of tumor prominence. As part of the metastases screening, abdominal ultrasound, chest X-ray, and magnetic resonance imaging (MRI) of the brain and orbits were performed regularly, with additional positron emission tomography (PET) combined with MRI performed as required.

Results:  In our cohort, the three-year eye preservation rate was 72.7%, while the three-year local tumor control reached the level of 75.8%. The three-year survival was 81.8%. Overall, metastases were detected in 30.3% of patients with the liver being affected in 44% of cases, the bones in 28%, and the lungs in 17%. The most common ocular complications of radiotherapy included cataracts (58.3% of phakic patients), neovascular glaucoma (39.4%), radiation maculopathy (27.3%) and radiation retinopathy (18.2%).

Conclusion:  Stereotactic radiosurgery is a safe treatment method for uveal melanoma with the potential for eye preservation. However, it carries the risk of tumor recurrence and ocular complications. Three-year survival and the incidence of ocular complications in our study were consistent with the data reported in the literature. By contrast, three-year local tumor control reached lower values compared to the relevant studies. Some results may be limited due to the small number of subjects in our cohort.

目的:评价立体定向放射治疗葡萄膜黑色素瘤患者的三年生存率、局部肿瘤控制率及并发症,并与已有文献进行比较。材料和方法:在本研究中,对122例接受葡萄膜黑色素瘤治疗的患者的数据进行了评估,其中33例符合使用射波刀系统对立体定向放射手术结果进行回顾性分析的纳入标准。这些患者在2016-2021年期间接受了葡萄膜黑色素瘤放疗。定期随访,包括最佳矫正视力评估、裂隙灯检查、间接检眼镜、眼压测量和超声测量肿瘤突出度。作为转移筛查的一部分,定期进行腹部超声、胸部x线、脑和眼眶磁共振成像(MRI)检查,并根据需要进行正电子发射断层扫描(PET)和MRI检查。结果:本组患者3年保眼率为72.7%,3年局部肿瘤控制率为75.8%。3年生存率为81.8%。总体而言,30.3%的患者检测到转移,44%的患者肝脏受到影响,28%的患者骨骼受到影响,17%的患者肺部受到影响。最常见的眼部并发症包括白内障(58.3%)、新生血管性青光眼(39.4%)、放射线黄斑病变(27.3%)和放射线视网膜病变(18.2%)。结论:立体定向放射手术治疗葡萄膜黑色素瘤是一种安全的治疗方法,具有保护眼睛的潜力。然而,它有肿瘤复发和眼部并发症的风险。本研究的三年生存率和眼部并发症发生率与文献报道的数据一致。与相关研究相比,3年局部肿瘤控制值较低。由于我们队列中的受试者数量较少,一些结果可能受到限制。
{"title":"Stereotactic Radiosurgery Outcomes in Uveal Melanoma Patients: A 3-year Retrospective Study.","authors":"Jozef Sklenka, Pavla Horňáčková, Daniela Vysloužilová, Veronika Matušková, Jan Němčanský, Radoslava Uhmannová, Moussa Goutaib, Oldřich Chrapek","doi":"10.31348/2025/48","DOIUrl":"https://doi.org/10.31348/2025/48","url":null,"abstract":"<p><strong>Aim: </strong> To evaluate the three-year survival rate, local tumor control rate and complications of stereotactic radiosurgery in patients with uveal melanoma and compare the outcomes with the available literature.</p><p><strong>Material and methods: </strong> In this study, data were evaluated from 122 patients treated for uveal melanoma, of whom 33 met the inclusion criteria for retrospective analysis of stereotactic radiosurgery outcomes using the CyberKnife system. These patients received radiotherapy for uveal melanoma during the period of 2016-2021. The data were collected during regular follow-up visits consisting of best-corrected visual acuity assessment, slit-lamp examination, indirect ophthalmoscopy, intraocular pressure measurement and ultrasound measurement of tumor prominence. As part of the metastases screening, abdominal ultrasound, chest X-ray, and magnetic resonance imaging (MRI) of the brain and orbits were performed regularly, with additional positron emission tomography (PET) combined with MRI performed as required.</p><p><strong>Results: </strong> In our cohort, the three-year eye preservation rate was 72.7%, while the three-year local tumor control reached the level of 75.8%. The three-year survival was 81.8%. Overall, metastases were detected in 30.3% of patients with the liver being affected in 44% of cases, the bones in 28%, and the lungs in 17%. The most common ocular complications of radiotherapy included cataracts (58.3% of phakic patients), neovascular glaucoma (39.4%), radiation maculopathy (27.3%) and radiation retinopathy (18.2%).</p><p><strong>Conclusion: </strong> Stereotactic radiosurgery is a safe treatment method for uveal melanoma with the potential for eye preservation. However, it carries the risk of tumor recurrence and ocular complications. Three-year survival and the incidence of ocular complications in our study were consistent with the data reported in the literature. By contrast, three-year local tumor control reached lower values compared to the relevant studies. Some results may be limited due to the small number of subjects in our cohort.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"81 Ahead of Print","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of 50 Most Cited Articles About Refractive Surgery From an Altmetric Perspective. 从 Altmetric 角度分析有关屈光手术的 50 篇最常被引用的文章。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.31348/2024/13
Mustafa Berhuni, Ozer Zeynep Ozcan

Aims: The purpose of this study is to evaluate an Altmetric analysis of the 50 most cited refractive surgery articles in Ophthalmology journals and to compare them with traditional metrics.

Methods: The term "refractive surgery" was searched, using a time filter between 2010-2020 in the Web of Science core collection database. The 50 most cited articles between 2010 and 2020 were recorded. Descriptive statistics were performed. The Spearman correlation test was used to evaluate the correlation between traditional metrics and Altmetrics.

Results: The Altmetric scores of the top 50 articles ranged from 0 to 25, and the median Altmetric score was 4. The citation numbers of the 50 articles ranged from 83 to 523, and the median citation number was 119.5. The most cited article topic was "Toric Intraocular Lens"; the topics with the highest Altmetric scores were "Toric Intraocular Lens" and "Trifocal Intraocular Lens". There was no significant correlation between Altmetric scores and number of citations. There was a weak correlation between Altmetric scores and the average citation per year.

Conclusion: The Altmetric score is insufficient, compared with traditional metrics, to show the scientific value of articles on refractive surgery. Altmetrics can be used to supplement traditional metrics.

目的:本研究旨在评估 Altmetric 对眼科期刊中被引用次数最多的 50 篇屈光手术文章进行的分析,并将其与传统指标进行比较:方法:在Web of Science核心数据库中使用时间过滤器搜索 "屈光手术 "一词,时间范围为2010-2020年。记录了 2010-2020 年间被引用次数最多的 50 篇文章。进行了描述性统计。斯皮尔曼相关检验用于评估传统指标与 Altmetrics 之间的相关性:前 50 篇文章的 Altmetric 分数在 0 到 25 之间,中位数为 4;50 篇文章的引用次数在 83 到 523 之间,中位数为 119.5。被引用次数最多的文章主题是 "散光眼内透镜";Altmetric得分最高的主题是 "散光眼内透镜 "和 "三焦点眼内透镜"。Altmetric 分数与引用次数之间没有明显的相关性。结论:与传统指标相比,Altmetric 分数不足以显示屈光手术文章的科学价值。Altmetric可作为传统指标的补充。
{"title":"Analysis of 50 Most Cited Articles About Refractive Surgery From an Altmetric Perspective.","authors":"Mustafa Berhuni, Ozer Zeynep Ozcan","doi":"10.31348/2024/13","DOIUrl":"10.31348/2024/13","url":null,"abstract":"<p><strong>Aims: </strong>The purpose of this study is to evaluate an Altmetric analysis of the 50 most cited refractive surgery articles in Ophthalmology journals and to compare them with traditional metrics.</p><p><strong>Methods: </strong>The term \"refractive surgery\" was searched, using a time filter between 2010-2020 in the Web of Science core collection database. The 50 most cited articles between 2010 and 2020 were recorded. Descriptive statistics were performed. The Spearman correlation test was used to evaluate the correlation between traditional metrics and Altmetrics.</p><p><strong>Results: </strong>The Altmetric scores of the top 50 articles ranged from 0 to 25, and the median Altmetric score was 4. The citation numbers of the 50 articles ranged from 83 to 523, and the median citation number was 119.5. The most cited article topic was \"Toric Intraocular Lens\"; the topics with the highest Altmetric scores were \"Toric Intraocular Lens\" and \"Trifocal Intraocular Lens\". There was no significant correlation between Altmetric scores and number of citations. There was a weak correlation between Altmetric scores and the average citation per year.</p><p><strong>Conclusion: </strong>The Altmetric score is insufficient, compared with traditional metrics, to show the scientific value of articles on refractive surgery. Altmetrics can be used to supplement traditional metrics.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"80 Ahead of print","pages":"248-255"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140289097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repeatability of Noninvasive Break-Up Time Measurements using Keratograph Oculus 3. 使用 Keratograph Oculus 3 进行无创破裂时间测量的重复性。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.31348/2024/26
Lenka Musilová, Alena Vodičková, František Pluháček

Aim: The primary aim of this study is to evaluate the repeatability of noninvasive break-up time (NIBUT) measurement by keratograph when it is determined from one, two or three partial measurements, and to recommend a suitable methodology for practice. Another goal is to verify that repeated measurements do not affect the measured value.

Material and methods: Thirty-eight healthy volunteers (30 women and 8 men) aged between 19 and 50 years old were included in the study, in which only one eye of each volunteer was measured. The study was designed as a prospective one. Each subject adapted to the local conditions of the laboratory for 15 minutes and subsequently underwent two series of NIBUT measurements (test, retest) on an OCULUS 3 Keratograph. The minimum time interval between the two series was 10 minutes, in which each series contained three partial measurements approximately 3 three measurements in the given series. Repeatability was assessed by a Bland-Altman analysis and expressed as a repeatability coefficient. In every case, only the time of the first break-up of the tear film was monitored.

Results: The statistical analysis did not show statistically significant differences both between partial measurements of NIBUT in the individual series (p = 0.92, p = 0.81) and when comparing all six measurements (p = 0.95). The mean values of the partial measurements ranged from 13.6 s to 14.4 s. The repeatability coefficients were found to be 15.0 s, 12.1 s and 10.0 s for methodologies A, B and C, respectively. A supplementary analysis for 12 eyes with low NIBUT (< 10 s) showed statistically significantly better repeatability in this group, with coefficients of 7.0 s (methodology A), 6.0 s (B) and 4.6 s (C).

Conclusion: Determination of NIBUT from three consecutive measurements (with a sufficient interval of ideally a few minutes) significantly improves repeatability. Such repeated NIBUT measurements do not have a significant effect on the measured value. The mentioned methodology for measuring NIBUT on a keratograph can be recommended for use in practice.

目的:本研究的主要目的是评估角膜塑形镜测量无创破裂时间(NIBUT)的重复性,即通过一次、两次或三次局部测量确定的重复性,并为实践推荐合适的方法。另一个目标是验证重复测量不会影响测量值:研究对象包括 38 名健康志愿者(30 名女性和 8 名男性),年龄在 19 岁至 50 岁之间,其中只测量了每名志愿者的一只眼睛。该研究为前瞻性研究。每位受试者在实验室适应当地条件 15 分钟,然后在 OCULUS 3 角膜塑形镜上进行两组 NIBUT 测量(测试、复测)。两个系列之间的最小时间间隔为 10 分钟,其中每个系列包含三次局部测量,每次测量约为给定系列中的三次测量。重复性通过布兰-阿尔特曼分析进行评估,并以重复性系数表示。在每种情况下,只监测泪膜第一次破裂的时间:统计分析结果表明,在单个系列的 NIBUT 部分测量值之间(p = 0.92,p = 0.81)以及在比较所有六次测量值时(p = 0.95),均无显著统计学差异。方法 A、B 和 C 的重复性系数分别为 15.0 秒、12.1 秒和 10.0 秒。对 12 只 NIBUT 值低(< 10 秒)的眼睛进行的补充分析表明,这组眼睛的重复性在统计学上明显更好,系数分别为 7.0 秒(方法 A)、6.0 秒(B)和 4.6 秒(C):结论:通过三次连续测量(间隔时间最好为几分钟)确定 NIBUT 可显著提高重复性。这种重复的 NIBUT 测量对测量值没有明显影响。上述在角膜塑形镜上测量 NIBUT 的方法可推荐在实践中使用。
{"title":"Repeatability of Noninvasive Break-Up Time Measurements using Keratograph Oculus 3.","authors":"Lenka Musilová, Alena Vodičková, František Pluháček","doi":"10.31348/2024/26","DOIUrl":"10.31348/2024/26","url":null,"abstract":"<p><strong>Aim: </strong>The primary aim of this study is to evaluate the repeatability of noninvasive break-up time (NIBUT) measurement by keratograph when it is determined from one, two or three partial measurements, and to recommend a suitable methodology for practice. Another goal is to verify that repeated measurements do not affect the measured value.</p><p><strong>Material and methods: </strong>Thirty-eight healthy volunteers (30 women and 8 men) aged between 19 and 50 years old were included in the study, in which only one eye of each volunteer was measured. The study was designed as a prospective one. Each subject adapted to the local conditions of the laboratory for 15 minutes and subsequently underwent two series of NIBUT measurements (test, retest) on an OCULUS 3 Keratograph. The minimum time interval between the two series was 10 minutes, in which each series contained three partial measurements approximately 3 three measurements in the given series. Repeatability was assessed by a Bland-Altman analysis and expressed as a repeatability coefficient. In every case, only the time of the first break-up of the tear film was monitored.</p><p><strong>Results: </strong>The statistical analysis did not show statistically significant differences both between partial measurements of NIBUT in the individual series (p = 0.92, p = 0.81) and when comparing all six measurements (p = 0.95). The mean values of the partial measurements ranged from 13.6 s to 14.4 s. The repeatability coefficients were found to be 15.0 s, 12.1 s and 10.0 s for methodologies A, B and C, respectively. A supplementary analysis for 12 eyes with low NIBUT (&lt; 10 s) showed statistically significantly better repeatability in this group, with coefficients of 7.0 s (methodology A), 6.0 s (B) and 4.6 s (C).</p><p><strong>Conclusion: </strong>Determination of NIBUT from three consecutive measurements (with a sufficient interval of ideally a few minutes) significantly improves repeatability. Such repeated NIBUT measurements do not have a significant effect on the measured value. The mentioned methodology for measuring NIBUT on a keratograph can be recommended for use in practice.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"80 Ahead of print","pages":"266-270"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141459883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ULTRASOUND EXAMINATION OF THE ORBIT IN PATIENTS WITH THYROIDASSOCIATED ORBITOPATHY - EXAMINATION GUIDE AND RECOMMENDATIONS FOR EVERYDAY PRACTICE. A REVIEW. 甲状腺相关性眶病患者的眼眶超声检查--检查指南和日常实践建议。综述。
Q4 Medicine Pub Date : 2024-01-01
M Karhanová, J Čivrný, J Kalitová, J Schovánek, M Malušková, M Hrevuš, Z Schreiberová

The purpose of this study is to present the possibilities and benefits of ultrasonography (US) of the orbit in the diagnosis and treatment of thyroidassociated orbitopathy (TAO). Methods: US examination of the orbit is an essential addition to clinical and laboratory examination in TAO patients. Nevertheless, it is often neglected in clinical practice or indicated with delay. Based on previously published studies and our experience with the diagnosis and treatment of TAO patients, we aim to highlight the clear benefit of US examination of the orbit and oculomotor muscles, not only for correct TAO diagnosis but also in the monitoring of the disease over time. However, knowledge of the drawbacks and limitations of this method is also essential, as we shall point out. It is always necessary to remember that US examination must be evaluated in connection with the clinical findings. A detailed recommendation for US examination of the extraocular muscles and the orbit based on our experiences with diagnosing and treating TAO patients in daily practice is also included. Conclusion: According to our experience, US examination of the orbit is an excellent and irreplaceable tool for timely TAO diagnosis and further disease monitoring. However, considerable examiner experience and detailed knowledge of the clinical and ultrasound manifestations of TAO are essential.

本研究旨在介绍眼眶超声成像(US)在诊断和治疗甲状腺相关性眼眶病(TAO)方面的可能性和优势。方法:眼眶超声检查是对TAO患者进行临床和实验室检查的重要补充。然而,在临床实践中,这项检查常常被忽视或延误。根据以前发表的研究和我们对 TAO 患者的诊断和治疗经验,我们旨在强调眼眶和眼球运动肌肉 US 检查的明显益处,它不仅有助于 TAO 的正确诊断,还有助于对疾病进行长期监测。不过,正如我们将要指出的,了解这种方法的缺点和局限性也是至关重要的。必须始终牢记,必须结合临床发现对 US 检查进行评估。我们还将根据日常诊断和治疗 TAO 患者的经验,对眼外肌和眼眶的 US 检查提出详细建议。结论:根据我们的经验,眼眶的 US 检查是及时诊断 TAO 和进一步监测疾病不可替代的绝佳工具。不过,检查者必须具备丰富的经验,并详细了解 TAO 的临床和超声表现。
{"title":"ULTRASOUND EXAMINATION OF THE ORBIT IN PATIENTS WITH THYROIDASSOCIATED ORBITOPATHY - EXAMINATION GUIDE AND RECOMMENDATIONS FOR EVERYDAY PRACTICE. A REVIEW.","authors":"M Karhanová, J Čivrný, J Kalitová, J Schovánek, M Malušková, M Hrevuš, Z Schreiberová","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The purpose of this study is to present the possibilities and benefits of ultrasonography (US) of the orbit in the diagnosis and treatment of thyroidassociated orbitopathy (TAO). Methods: US examination of the orbit is an essential addition to clinical and laboratory examination in TAO patients. Nevertheless, it is often neglected in clinical practice or indicated with delay. Based on previously published studies and our experience with the diagnosis and treatment of TAO patients, we aim to highlight the clear benefit of US examination of the orbit and oculomotor muscles, not only for correct TAO diagnosis but also in the monitoring of the disease over time. However, knowledge of the drawbacks and limitations of this method is also essential, as we shall point out. It is always necessary to remember that US examination must be evaluated in connection with the clinical findings. A detailed recommendation for US examination of the extraocular muscles and the orbit based on our experiences with diagnosing and treating TAO patients in daily practice is also included. Conclusion: According to our experience, US examination of the orbit is an excellent and irreplaceable tool for timely TAO diagnosis and further disease monitoring. However, considerable examiner experience and detailed knowledge of the clinical and ultrasound manifestations of TAO are essential.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"3 Ahead of Print","pages":"3-11"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9076113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Intravitreal Aflibercept on Corneal Endothelial Cells. 玻璃体内阿弗利百普对角膜内皮细胞的影响
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.31348/2024/18
Zuzana Šulavíková, Zuzana Šustykevičová, Marek Káčerik, Vladimír Krásnik

Aim: To determine the effect of repeated intravitreal injections of aflibercept on the corneal endothelium in patients with diabetic macular edema (DME) and macular edema due to retinal vein occlusion (RVO).

Methods: In a prospective study conducted between January 2021 and November 2023, a total of 87 treatment-naive eyes with DME and RVO were evaluated. The exclusion criteria were surgery or laser intervention during the follow-up period, contact lens wear, cataract surgery in the last 6 months, dystrophy, or other corneal condition that may cause endothelial damage. In addition to routine examinations on the day of application, we also measured the corneal endothelium using specular microscopy on the 1st, 4th and 8th day of injection. We evaluated 4 parameters: endothelial cell density (CD), hexagonality (HEX), coefficient of variability (CV) and central corneal thickness (CCT). First of all, we evaluated the entire cohort of eyes, and then divided it according to 2 criteria; the diagnosis into DME/RVO and according to the lens status into phakic/pseudophakic eyes.

Results: A total of 87 eyes of 68 patients were evaluated. The average age of the patients at the time of diagnosis was 66.8 ±9.3 years. Within the cohort 51 (59%) eyes were phakic and 36 (41%) pseudophakic. A total of 61 (70%) eyes with a diagnosis of DME were treated, and 26 (30%) with RVO. During the follow-up, there were no significant changes in the average values of CD, HEX, CV, CCT due to aflibercept treatment, either in the whole group or in subgroups according to diagnosis or lens condition.

Conclusions: The results of this study suggest that intravitreal administration of aflibercept in patients with DME and RVO did not have an impact on corneal endothelial parameters, including CCT, HEX, CD and CV. These parameters were measured using endothelial microscopy during an 8-injection observation period.

目的:确定重复玻璃体内注射aflibercept对糖尿病性黄斑水肿(DME)和视网膜静脉闭塞(RVO)引起的黄斑水肿患者角膜内皮的影响: 在 2021 年 1 月至 2023 年 11 月期间进行的一项前瞻性研究中,共评估了 87 例未接受过治疗的 DME 和 RVO 患者。排除标准为随访期间接受过手术或激光干预、佩戴过隐形眼镜、在过去 6 个月内接受过白内障手术、角膜营养不良或其他可能导致角膜内皮损伤的角膜病症。除了在注射当天进行常规检查外,我们还在注射后的第 1 天、第 4 天和第 8 天使用镜检显微镜测量了角膜内皮。我们评估了四个参数:内皮细胞密度(CD)、六角形度(HEX)、变异系数(CV)和角膜中央厚度(CCT)。首先,我们对所有眼球进行了评估,然后根据两个标准进行了划分:根据诊断分为 DME/RVO,根据晶状体状态分为隐形/假性: 结果:共对 68 名患者的 87 只眼睛进行了评估。结果:共评估了 68 名患者的 87 只眼睛,诊断时患者的平均年龄为 66.8 ± 9.3 岁。其中 51 只(59%)为法眼球,36 只(41%)为假性法眼球。共有 61 只(70%)眼睛被诊断为 DME,26 只(30%)眼睛被诊断为 RVO。在随访期间,无论是整组还是根据诊断或晶状体情况划分的亚组,阿弗利百普治疗对CD、HEX、CV、CCT的平均值均无显著变化: 本研究结果表明,在DME和RVO患者中静脉注射aflibercept不会影响角膜内皮参数,包括CCT、HEX、CD和CV。这些参数是在8次注射观察期间使用内皮显微镜测量的。
{"title":"Effect of Intravitreal Aflibercept on Corneal Endothelial Cells.","authors":"Zuzana Šulavíková, Zuzana Šustykevičová, Marek Káčerik, Vladimír Krásnik","doi":"10.31348/2024/18","DOIUrl":"10.31348/2024/18","url":null,"abstract":"<p><strong>Aim: </strong>To determine the effect of repeated intravitreal injections of aflibercept on the corneal endothelium in patients with diabetic macular edema (DME) and macular edema due to retinal vein occlusion (RVO).</p><p><strong>Methods: </strong>In a prospective study conducted between January 2021 and November 2023, a total of 87 treatment-naive eyes with DME and RVO were evaluated. The exclusion criteria were surgery or laser intervention during the follow-up period, contact lens wear, cataract surgery in the last 6 months, dystrophy, or other corneal condition that may cause endothelial damage. In addition to routine examinations on the day of application, we also measured the corneal endothelium using specular microscopy on the 1st, 4th and 8th day of injection. We evaluated 4 parameters: endothelial cell density (CD), hexagonality (HEX), coefficient of variability (CV) and central corneal thickness (CCT). First of all, we evaluated the entire cohort of eyes, and then divided it according to 2 criteria; the diagnosis into DME/RVO and according to the lens status into phakic/pseudophakic eyes.</p><p><strong>Results: </strong>A total of 87 eyes of 68 patients were evaluated. The average age of the patients at the time of diagnosis was 66.8 ±9.3 years. Within the cohort 51 (59%) eyes were phakic and 36 (41%) pseudophakic. A total of 61 (70%) eyes with a diagnosis of DME were treated, and 26 (30%) with RVO. During the follow-up, there were no significant changes in the average values of CD, HEX, CV, CCT due to aflibercept treatment, either in the whole group or in subgroups according to diagnosis or lens condition.</p><p><strong>Conclusions: </strong>The results of this study suggest that intravitreal administration of aflibercept in patients with DME and RVO did not have an impact on corneal endothelial parameters, including CCT, HEX, CD and CV. These parameters were measured using endothelial microscopy during an 8-injection observation period.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"80 Ahead of print","pages":"202-207"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Central Serous Chorioretinopathy. A Review. 中心性浆液性脉络膜视网膜病变。综述。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.31348/2023/27
Kateřina Myslík Manethová

Central serous chorioretinopathy (CSC) is a disease characterized by serous detachment of the neuroretina, especially in the posterior pole of the eye. It is often accompanied by serous detachment of the retinal pigment epithelium (RPE) and associated with the leakage of fluid into the subretinal space through the defective RPE. CSC most often affects men of working age. The exact pathophysiology of the disease is not completely known. Based on indocyanine green angiography (ICG), which revealed increased permeability of choroidal vessels, and optical coherence tomography (OCT) showing increased choroidal thickness, choroidal vasculopathy is assumed to be the primary cause of CSC. In most cases, CSC has a good prognosis with spontaneous resorption of the subretinal fluid (SRF) and improvement of visual functions. However, in a small percentage of patients the disease progresses to a chronic or recurrent course, and can lead to irreversible functional and anatomical changes of the retina with a final clinical picture of diffuse retinal pigment epitheliopathy (DRPE). The optimal treatment approach for patients with CSC remains controversial. In recent decades, myriad therapeutic approaches have been used in the treatment of chronic forms of CSC (cCSC); these included for example laser photocoagulation, pharmaceutical treatment, standard photodynamic therapy (PDT) or anti-VEGF. In recent years a less destructive method, specifically PDT in reduced dose regimens, either with a reduced dose of verteporfin or the laser beam energy used, has been preferred in the treatment of cCSC. Comparable efficacy and safety has been demonstrated using reduced-dose or reduced-fluence PDT regimens in patients with cCSC, with an improvement in best-corrected visual acuity and reduction of SRF.

中心性浆液性脉络膜视网膜病变(CSC)是一种以神经视网膜浆液性脱离为特征的疾病,尤其是在眼球后极部。它通常伴有视网膜色素上皮(RPE)的浆液性脱离,并伴有液体通过有缺陷的 RPE 渗漏到视网膜下间隙。CSC 最常影响工作年龄的男性。该病的确切病理生理学尚不完全清楚。吲哚菁绿血管造影术(ICG)显示脉络膜血管的通透性增加,光学相干断层扫描(OCT)显示脉络膜厚度增加,因此脉络膜血管病变被认为是 CSC 的主要病因。在大多数情况下,CSC 的预后良好,视网膜下积液(SRF)会自发吸收,视功能也会得到改善。然而,也有一小部分患者的病情会发展为慢性或复发性病程,并可能导致视网膜发生不可逆的功能和解剖学改变,最终临床表现为弥漫性视网膜色素上皮病变(DRPE)。CSC患者的最佳治疗方法仍存在争议。近几十年来,治疗慢性 CSC(cCSC)的方法层出不穷,其中包括激光光凝、药物治疗、标准光动力疗法(PDT)或抗血管内皮生长因子(anti-VEGF)等。近年来,一种破坏性较小的方法,特别是减少剂量方案中的光动力疗法,无论是减少维替泊芬的剂量还是减少激光束的能量,已成为治疗 cCSC 的首选方法。在治疗 cCSC 患者时,减小剂量或减小能量的光动力疗法已被证明具有相当的疗效和安全性,并能改善最佳矫正视力和减少 SRF。
{"title":"Central Serous Chorioretinopathy. A Review.","authors":"Kateřina Myslík Manethová","doi":"10.31348/2023/27","DOIUrl":"10.31348/2023/27","url":null,"abstract":"<p><p>Central serous chorioretinopathy (CSC) is a disease characterized by serous detachment of the neuroretina, especially in the posterior pole of the eye. It is often accompanied by serous detachment of the retinal pigment epithelium (RPE) and associated with the leakage of fluid into the subretinal space through the defective RPE. CSC most often affects men of working age. The exact pathophysiology of the disease is not completely known. Based on indocyanine green angiography (ICG), which revealed increased permeability of choroidal vessels, and optical coherence tomography (OCT) showing increased choroidal thickness, choroidal vasculopathy is assumed to be the primary cause of CSC. In most cases, CSC has a good prognosis with spontaneous resorption of the subretinal fluid (SRF) and improvement of visual functions. However, in a small percentage of patients the disease progresses to a chronic or recurrent course, and can lead to irreversible functional and anatomical changes of the retina with a final clinical picture of diffuse retinal pigment epitheliopathy (DRPE). The optimal treatment approach for patients with CSC remains controversial. In recent decades, myriad therapeutic approaches have been used in the treatment of chronic forms of CSC (cCSC); these included for example laser photocoagulation, pharmaceutical treatment, standard photodynamic therapy (PDT) or anti-VEGF. In recent years a less destructive method, specifically PDT in reduced dose regimens, either with a reduced dose of verteporfin or the laser beam energy used, has been preferred in the treatment of cCSC. Comparable efficacy and safety has been demonstrated using reduced-dose or reduced-fluence PDT regimens in patients with cCSC, with an improvement in best-corrected visual acuity and reduction of SRF.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"80 2","pages":"59-75"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140294867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vogt-Koyanagi-Harada Disease: The Clinical Spectrum and Management of Case Series in a Tertiary Eye Centre in Northern Part Of Malaysia. Vogt-Koyanagi-Harada 病:马来西亚北部一家三级眼科中心的临床谱系和病例系列管理。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.31348/2024/1
Atiqah Nur Hasan, Mushawiahti Mustapha, Haslina Abdul Halim Wan Wan

Aims: We present the clinical spectrum, the initial clinical presentation with management trends in treating 14 Vogt-Koyanagi-Harada (VKH) disease cases in a tertiary center in the Northern part of Malaysia.

Case series: There were 14 cases of Vogt-Koyanagi-Harada (VKH) disease retrospectively reviewed over five years (from 2015 to 2020). The mean age at presentation was 37.7 years (range 21-64 years), with female predominance (85.7%). All cases presented with acute uveitic stage and bilateral eye involvement. Of them, 11 (78.6%) were probable VKH, and three (21.4%) were incomplete VKH. All patients attended with acute panuveitis at first presentation. The main posterior segment involvement was disc edema in 57.1% (16 out of 28 eyes) and exudative retinal detachment (ERD) in 35.7% (10 out of 28 eyes). Most of them presented with blindness (3/60 and worse) and moderate visual impair- ment (6/18-6/60); 35.71% each, followed by mild visual impairment (6/12-6/18), and severe visual impairment (6/60-3/60); 7.1% each. Ten patients (71.4%) required combination second-line immunomodulatory treatment during subsequent visits, and only four patients (28.6%) responded well to corticosteroid therapy. Most of the cases achieved no visual impairment (64.3%), followed by mild visual impairment (21.4%) and moderate visual impairment (14.3%), and none were severe or blind at the end of follow-up.

Conclusion: VKH is a potentially blinding illness if there is inadequate control of the disease in the acute stage. Most of our patients achieved good visual outcomes with early immunomodulatory treatment and systemic corticosteroids.

目的:我们介绍了马来西亚北部一家三级医疗中心治疗14例Vogt-Koyanagi-Harada(VKH)病例的临床谱系、初始临床表现和管理趋势:回顾性分析了五年来(2015年至2020年)的14例Vogt-Koyanagi-Harada(VKH)病例。平均发病年龄为 37.7 岁(21-64 岁不等),女性占多数(85.7%)。所有病例均表现为急性葡萄膜炎阶段和双眼受累。其中 11 例(78.6%)可能患有 VKH,3 例(21.4%)为不完全 VKH。所有患者首次就诊时都患有急性泛葡萄膜炎。视网膜后段主要受累于视盘水肿(57.1%,28 眼中有 16 眼)和渗出性视网膜脱离(ERD)(35.7%,28 眼中有 10 眼)。大多数患者表现为失明(3/60 或更严重)和中度视力障碍(6/18-6/60),各占 35.71%,其次是轻度视力障碍(6/12-6/18)和重度视力障碍(6/60-3/60),各占 7.1%。10名患者(71.4%)在随后的就诊中需要联合二线免疫调节治疗,只有4名患者(28.6%)对皮质类固醇治疗反应良好。大多数病例无视力障碍(64.3%),其次是轻度视力障碍(21.4%)和中度视力障碍(14.3%),随访结束时无重度或失明病例:结论:如果在急性期控制不当,VKH可能会致盲。结论:如果在急性期控制不当,VKH可能会致盲。我们的大多数患者在接受早期免疫调节治疗和全身皮质类固醇治疗后,视力恢复良好。
{"title":"Vogt-Koyanagi-Harada Disease: The Clinical Spectrum and Management of Case Series in a Tertiary Eye Centre in Northern Part Of Malaysia.","authors":"Atiqah Nur Hasan, Mushawiahti Mustapha, Haslina Abdul Halim Wan Wan","doi":"10.31348/2024/1","DOIUrl":"10.31348/2024/1","url":null,"abstract":"<p><strong>Aims: </strong>We present the clinical spectrum, the initial clinical presentation with management trends in treating 14 Vogt-Koyanagi-Harada (VKH) disease cases in a tertiary center in the Northern part of Malaysia.</p><p><strong>Case series: </strong>There were 14 cases of Vogt-Koyanagi-Harada (VKH) disease retrospectively reviewed over five years (from 2015 to 2020). The mean age at presentation was 37.7 years (range 21-64 years), with female predominance (85.7%). All cases presented with acute uveitic stage and bilateral eye involvement. Of them, 11 (78.6%) were probable VKH, and three (21.4%) were incomplete VKH. All patients attended with acute panuveitis at first presentation. The main posterior segment involvement was disc edema in 57.1% (16 out of 28 eyes) and exudative retinal detachment (ERD) in 35.7% (10 out of 28 eyes). Most of them presented with blindness (3/60 and worse) and moderate visual impair- ment (6/18-6/60); 35.71% each, followed by mild visual impairment (6/12-6/18), and severe visual impairment (6/60-3/60); 7.1% each. Ten patients (71.4%) required combination second-line immunomodulatory treatment during subsequent visits, and only four patients (28.6%) responded well to corticosteroid therapy. Most of the cases achieved no visual impairment (64.3%), followed by mild visual impairment (21.4%) and moderate visual impairment (14.3%), and none were severe or blind at the end of follow-up.</p><p><strong>Conclusion: </strong>VKH is a potentially blinding illness if there is inadequate control of the disease in the acute stage. Most of our patients achieved good visual outcomes with early immunomodulatory treatment and systemic corticosteroids.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"80 Ahead of print","pages":"140-144"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139984135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refractive Surgery in a Patient with Alport Syndrome. A Case Report. 阿尔波特综合征患者的屈光手术。病例报告。
Q4 Medicine Pub Date : 2024-01-01 DOI: 10.31348/2024/28
Darina Pospíšilová, Iveta Němcová, Jiří Pašta, Kateřina Hladíková, Eva Vyplašilová, Jan Havlik, Jan Tesař, Martin Šín

The authors present a case of a thirty-eight-year-old patient with Alport syndrome. The patient had several ocular symptoms of the disease and has been treated for systemic problems in connection with Alport syndrome since he was fifteen years old. At that age the patient also underwent a kidney transplant in order to deal with renal insufficiency. To date, he still uses immunosuppressants and antihypertensives. Furthermore, the patient suffers from perceptive deafness. The patient visited our clinic in 2021 with a request to solve his high refractive error, in which the diopters were so high that it was not possible to place them in spectacles. The patient's best corrected visual acuity was 0.6 with -8.0sph/-4.0cyl/ax15 in the right eye and 0.7partim with -8.0sph/-4.0cyl/ax155 in the left eye. The autorefractometer values were -6.25sph/-6.75cyl/ax17 in the right eye and -6.75sph/-6.5cyl/ax155 in the left eye. During the eye examination we found a number of ocular manifestations that are typical of Alport syndrome. On the cornea there were opacities as a residue of corneal erosions, and at one of the following check-ups we also found a newly developed corneal erosion. Subsequently, we found an anterior lenticonus and incipient cataract. Upon performing OCT, a typical temporal macular atrophy was evident. Fundus examination in artificial mydriasis showed just a minimal manifestation of fleck retinopathy. Due to the clinical manifestation we decided to perform cataract surgery and implant a monofocal toric intraocular lens in both eyes. There were no complications during the operations, however the surgeon registered a non-standard structure of the lens capsule. The capsule was more fragile, and performing capsulorhexis was much more complicated. A week after the surgery, higher cylinder diopters were still present. A decrease of the higher diopters was noticeable one month after surgery. The time interval between the first operation and the second operation was one month. The patient was highly satisfied with result, and uncorrected visual acuity improved by over four lines. After surgery the patient needed low diopters for near as well as far distance. In the case of this patient, the ocular manifestations were detected and treated in adulthood. Nevertheless, early detection of ocular symptoms of Alport syndrome in young patients before renal failure could lead to timely start of the treatment and delay a possible renal transplant. In case of any suspicion of Alport syndrome it is advised to send the patient to a pediatrician, and at an older age to an internal medicine specialist, for further examination.

作者介绍了一例三十八岁的阿尔波特综合征患者。患者有多种眼部疾病症状,从十五岁起就开始接受与阿尔波特综合征有关的全身性治疗。在那个年纪,患者还接受了肾移植手术,以治疗肾功能不全。至今,他仍在使用免疫抑制剂和降压药。此外,患者还患有感知性耳聋。患者于 2021 年到我院就诊,要求解决他的高度屈光不正问题,因为他的屈光度数太高,无法配戴眼镜。患者右眼最佳矫正视力为-8.0sph/-4.0cyl/ax15,视力为 0.6;左眼最佳矫正视力为-8.0sph/-4.0cyl/ax155,视力为 0.7partim。自动屈光仪的数值为右眼-6.25sph/-6.75cyl/ax17,左眼-6.75sph/-6.5cyl/ax155。在眼部检查中,我们发现了一些阿尔波特综合征的典型眼部表现。角膜上有角膜侵蚀残留的不透明,在随后的一次检查中,我们还发现了新出现的角膜侵蚀。随后,我们又发现了前皮孔和初期白内障。在进行 OCT 检查时,我们发现了典型的颞黄斑萎缩。在人工昏迷状态下进行的眼底检查显示,仅有轻微的斑片状视网膜病变。根据临床表现,我们决定为他实施白内障手术,并在双眼植入单焦点散光人工晶体。手术过程中没有出现任何并发症,但医生发现晶状体囊的结构不符合标准。晶状体囊更加脆弱,进行囊外摘除术也更加复杂。手术一周后,仍有较高的圆柱度数。术后一个月,较高的屈光度数明显减少。第一次手术和第二次手术之间的时间间隔为一个月。患者对手术效果非常满意,未矫正视力提高了四行多。手术后,患者在近距离和远距离都需要低度数的屈光度。在这名患者的病例中,其眼部表现在成年后才被发现并得到治疗。不过,如果能在肾功能衰竭之前及早发现年轻患者的阿尔波特综合征眼部症状,就能及时开始治疗,并推迟可能的肾移植。如果怀疑患者患有阿尔波特综合征,建议将其送往儿科医生处做进一步检查,如果年龄较大,则送往内科专科医生处做进一步检查。
{"title":"Refractive Surgery in a Patient with Alport Syndrome. A Case Report.","authors":"Darina Pospíšilová, Iveta Němcová, Jiří Pašta, Kateřina Hladíková, Eva Vyplašilová, Jan Havlik, Jan Tesař, Martin Šín","doi":"10.31348/2024/28","DOIUrl":"10.31348/2024/28","url":null,"abstract":"<p><p>The authors present a case of a thirty-eight-year-old patient with Alport syndrome. The patient had several ocular symptoms of the disease and has been treated for systemic problems in connection with Alport syndrome since he was fifteen years old. At that age the patient also underwent a kidney transplant in order to deal with renal insufficiency. To date, he still uses immunosuppressants and antihypertensives. Furthermore, the patient suffers from perceptive deafness. The patient visited our clinic in 2021 with a request to solve his high refractive error, in which the diopters were so high that it was not possible to place them in spectacles. The patient's best corrected visual acuity was 0.6 with -8.0sph/-4.0cyl/ax15 in the right eye and 0.7partim with -8.0sph/-4.0cyl/ax155 in the left eye. The autorefractometer values were -6.25sph/-6.75cyl/ax17 in the right eye and -6.75sph/-6.5cyl/ax155 in the left eye. During the eye examination we found a number of ocular manifestations that are typical of Alport syndrome. On the cornea there were opacities as a residue of corneal erosions, and at one of the following check-ups we also found a newly developed corneal erosion. Subsequently, we found an anterior lenticonus and incipient cataract. Upon performing OCT, a typical temporal macular atrophy was evident. Fundus examination in artificial mydriasis showed just a minimal manifestation of fleck retinopathy. Due to the clinical manifestation we decided to perform cataract surgery and implant a monofocal toric intraocular lens in both eyes. There were no complications during the operations, however the surgeon registered a non-standard structure of the lens capsule. The capsule was more fragile, and performing capsulorhexis was much more complicated. A week after the surgery, higher cylinder diopters were still present. A decrease of the higher diopters was noticeable one month after surgery. The time interval between the first operation and the second operation was one month. The patient was highly satisfied with result, and uncorrected visual acuity improved by over four lines. After surgery the patient needed low diopters for near as well as far distance. In the case of this patient, the ocular manifestations were detected and treated in adulthood. Nevertheless, early detection of ocular symptoms of Alport syndrome in young patients before renal failure could lead to timely start of the treatment and delay a possible renal transplant. In case of any suspicion of Alport syndrome it is advised to send the patient to a pediatrician, and at an older age to an internal medicine specialist, for further examination.</p>","PeriodicalId":39839,"journal":{"name":"Ceska a Slovenska Oftalmologie","volume":"80 Ahead of print","pages":"332-337"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141459882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Ceska a Slovenska Oftalmologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1